|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.840 USD | +1.66% |
|
-2.13% | -3.82% |
| 05-14 | Serina Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-29 | Serina Therapeutics, Inc. announced that it has received $21.2 million in funding | CI |
| Market Cap | 27.41M 23.68M 21.82M 20.42M 38.27M 2.61B 38.87M 258M 100M 1.27B 103M 101M 4.39B | P/E Ratio 2026 * |
-1x | P/E Ratio 2027 * | -1.46x |
|---|---|---|---|---|---|
| Enterprise Value | 27.41M 23.68M 21.82M 20.42M 38.27M 2.61B 38.87M 258M 100M 1.27B 103M 101M 4.39B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
65.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.66% | ||
| 1 week | -2.13% | ||
| 1 month | +6.98% | ||
| 3 months | +18.71% | ||
| 6 months | -41.03% | ||
| Current year | -3.82% |
| 1 week | 1.71 |  | 1.95 |
| 1 month | 1.51 | | 2.03 |
| Current year | 1.22 | | 4.08 |
| 1 year | 1.22 | | 7.92 |
| 3 years | 1.22 | | 19.93 |
| 5 years | 1.22 | | 19.93 |
| 10 years | 1.22 | | 19.93 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-25 | Free | Chief Executive Officer | 10,100 | 0.0820% | ||
| 05-21 | Buy | Director | 10,000 | 0.0812% | ||
| 05-20 | Free | Chief Financial Officer | 123,019 | 0.9990% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.66% | -2.13% | -69.33% | - | 27.41M | |
| +1.03% | +2.30% | +55.91% | +115.16% | 56.42B | |
| +2.72% | +3.26% | +46.05% | +47.37% | 44.54B | |
| +1.12% | +2.79% | -15.04% | -18.40% | 22.9B | |
| +1.17% | +3.85% | -0.89% | +407.26% | 21.21B | |
| +3.81% | -5.07% | +11.00% | -29.60% | 16.4B | |
| +0.15% | +2.24% | +9.32% | -39.25% | 15.4B | |
| -0.69% | +0.82% | +27.75% | +182.91% | 13.35B | |
| +5.27% | +5.54% | +19.65% | - | 12.36B | |
| +1.61% | +1.28% | +95.75% | +206.59% | 11.15B | |
| Average | +1.78% | +1.67% | +18.02% | +109.00% | 21.38B | |
| Weighted average by Cap. | +1.72% | +2.37% | +32.03% | +101.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -27.86M -24.06M -22.17M -20.75M -38.89M -2.65B -39.49M -262M -102M -1.29B -105M -102M -4.46B | -29.36M -25.35M -23.36M -21.87M -40.98M -2.79B -41.62M -276M -108M -1.36B -110M -108M -4.7B |
| Net Debt | - | - |
Employees
16
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 1.840 $ | +1.66% | 161,863 |
| 26-06-11 | 1.810 $ | +4.02% | 1,143,952 |
| 26-06-10 | 1.740 $ | -1.69% | 55,087 |
| 26-06-09 | 1.770 $ | -6.84% | 85,620 |
| 26-06-08 | 1.900 $ | +1.06% | 60,733 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.840USD
Average target price
11.00USD
Spread / Average Target
+497.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SER Stock
Select your edition
All financial news and data tailored to specific country editions
